Related references
Note: Only part of the references are listed.Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
Frank Behrens et al.
JOURNAL OF RHEUMATOLOGY (2016)
Psoriatic arthritis: current therapy and future approaches
DoQuyen Huynh et al.
RHEUMATOLOGY (2015)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
Arthur Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria
Maldonado Ficco Hernan et al.
CLINICAL RHEUMATOLOGY (2014)
Updated Guidelines for the Management of Axial Disease in Psoriatic Arthritis
Peter Nash et al.
JOURNAL OF RHEUMATOLOGY (2014)
Inflammatory pathways in spondyloarthritis
Hulda S. Hreggvidsdottir et al.
MOLECULAR IMMUNOLOGY (2014)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
John D. Reveille et al.
NATURE GENETICS (2010)
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
C. Lukas et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Melanie Newport et al.
NATURE GENETICS (2007)
Presentation and analysis of data on radiographic outcome in clinical trials - Experience from the TEMPO study
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Share Paper
